PROCEPT BioRobotics Corporation (PRCT) Misses Q3 EPS by 1c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.51), $0.01 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $16.79 million.

GUIDANCE:

PROCEPT BioRobotics Corporation sees FY2022 revenue of $72.5 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• XP Inc. (XP) Tops Q2 EPS by 8c